Sanofi India declines despite reporting 11% rise in Q3 net profit

09 Nov 2016 Evaluate

Sanofi India is currently trading at Rs. 4180.55, down by 96.55 points or 2.26% from its previous closing of Rs. 4277.10 on the BSE.

The scrip opened at Rs. 4100.00 and has touched a high and low of Rs. 4231.15 and Rs. 4100.00 respectively. So far 149 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4770.00 on 04-Jul-2016 and a 52 week low of Rs. 3850.00 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs. 4330.00 and Rs. 4100.00 respectively. The current market cap of the company is Rs. 9622.19 crore.

The promoters holding in the company stood at 60.40%, while institutions and non-institutions held 29.13% and 10.47% respectively.

Sanofi India has reported 11.17% rise in its net profit at Rs 80.60 crore for the quarter under review as compared to Rs 72.50 crore for the same quarter in the previous year. Total income of the company increased by 7.36% at Rs 639.00 crore for the quarter under review as compared Rs 595.20 crore for the corresponding quarter previous year.  

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.

Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.